China Anlotinib Hydrochloride Market Analysis, Application & Forecast To 2021-2025

Submitted by James Grey | December 4, 2021, 07:44:25 | Business

Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Article source:

Tag: #china anlotinib hydrochloride market #china anlotinib hydrochloride market repor

Read More Stories:

Your email address will not be published. Required fields are marked *